SPONSOR
University of Florida
Total Trials
24
Recruiting
24
Phases
EARLY_Phase 1, Phase 1, Phase 4, Phase 1, Phase 2
Conditions studied: Heart Transplant RejectionImmune SuppressionPediatric Heart TransplantMedication NonadherenceHealth BehaviorRemote MonitoringPatient EngagementTrauma InjurySpinal Cord Injuries (SCI)Mild Dementia
University of Florida is a clinical research sponsor with 24 registered studies on ClinicalTrials.gov, of which 24 are actively recruiting participants. Research covers conditions including Heart Transplant Rejection, Immune Suppression, Pediatric Heart Transplant, Medication Nonadherence.
The trial portfolio spans EARLY_Phase 1, Phase 1, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of Florida
How many clinical trials has University of Florida sponsored?
ClinicalMetric currently tracks 24 clinical trials sponsored by University of Florida, of which 24 are actively recruiting participants. These trials cover conditions including Heart Transplant Rejection, Immune Suppression, Pediatric Heart Transplant. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Florida research focus on?
University of Florida clinical trials span Heart Transplant Rejection, Immune Suppression, Pediatric Heart Transplant, Medication Nonadherence, Health Behavior, and additional conditions. The research pipeline includes EARLY_Phase 1, Phase 1, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Florida clinical trial?
To participate in a University of Florida trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Florida trials with current recruitment status updated daily.
Clinical Trials by University of Florida
NCT05732779
Recruiting
Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients
Heart Transplant Rejection
NCT02577731
Recruiting
Hematopoietic Stem Cell Dysfunction in the Elderly After Severe Injury
Trauma Injury
NCT07002437
Recruiting
Hypoxia Pathways for Early Recovery After Spinal Cord Injury
Spinal Cord Injuries (SCI)
NCT05910619
Recruiting
Transcranial Pulse Stimulation of the Brain
Mild Dementia
NCT06977100
Recruiting
Journaling Intervention for Temporomandibular Disorder (TMD) and Chronic Overlapping Pain
Temporomandibular Disorders (TMD)
NCT02497534
Recruiting
Biomarkers in Friedreich's Ataxia
Friedreich's Ataxia
NCT06804512 EARLY_Phase 1
Recruiting
Intermittent Visual Perturbations to Enhance Balance Training
Balance
NCT06988995
Recruiting
Compassion Strikes Back
LVAD Caregivers
NCT06246409
Recruiting
Modernizing Instructions to Improve Treatment Participation of Subjects During Their First Radiotherapy
Cancer
NCT00411060
Recruiting
Clinical Orthopaedic Data Bank (Acute and Chronic)
Osteoarthritis
NCT06389591 Phase 1
Recruiting
RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
Recurrent Glioblastoma
NCT05457725
Recruiting
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
Aging
NCT07452939
Recruiting
Prefrontal Theta Burst Stimulation to Improve Cognitive Impairment After ICU Delirium
Post-delirium Cognitive Impairment
NCT07325487
Recruiting
Interposed Nucleus aDBS for Ataxia
Spinocerebellar Ataxia (SCA)
NCT05580614
Recruiting
Paired tVNS With ERP in OCD
OCD
NCT06246396 Phase 4
Recruiting
Antihypertensive Mechanisms of Minocycline in Resistant Hypertension
Hypertension, Resistant to Conventional Therapy
NCT07766980
Recruiting
Evaluating VM100 Nutritional Supplement for Improving Quality of Life in Duchenne Muscular Dystrophy Patients
Duchenne Muscular Dystrophy
NCT05000294 Phase 1, Phase 2
Recruiting
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Bile Duct Cancer
NCT07125378 Phase 1, Phase 2
Recruiting
Living Independence Through Functional Training
Mobility Limitation
NCT06514898 Phase 1
Recruiting
Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma
Recurrent Group 3 Medulloblastoma
NCT06414473 Phase 1, Phase 2
Recruiting
CBD for Knee Osteoarthritis
Osteoarthritis, Knee
NCT05127265
Recruiting
Pervasive Sensing and AI in Intelligent ICU
Critical Illness
NCT05616130
Recruiting
Pathological Myeloid Activation After Sepsis and Trauma
Trauma Injury
NCT07475039
Recruiting
Project HOPEFUL: A PN-RCT With Implementation Science
Older Adults (50-90 Years)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology